LSE Regulatory News

Information on this page is updated via a feed from the London Stock Exchange's Regulatory News Service. To retrieve the full story please click on the headline. Stories will open in a new window.

Search Options

Keyword:Search range:
Time period or between and 

 

<< Previous    

Search Results

Date:Source:Time:Headline:
28/11/2016 Reg : 07:00  ISSUE OF SHARE OPTIONS
24/11/2016 Reg : 14:48  Result of GM
04/11/2016 Reg : 07:00  Barts Research Supports Potential Use of Parsortix
01/11/2016 Reg : 07:00  Notice of GM
27/10/2016 Reg : 07:00  Director's share purchase
07/10/2016 Reg : 11:57  Holding(s) in Company
04/10/2016 Reg : 16:35  Result of AGM
30/09/2016 Reg : 07:00  Research published in Clinical Chemistry
19/09/2016 Reg : 11:14  Issue of Equity
09/09/2016 Reg : 16:12  Annual Report and Accounts and Notice of AGM
04/08/2016 Reg : 07:00  MD Anderson Cancer Center poster presentation
02/08/2016 Reg : 15:37  Edison issues ADR update on Angle
28/07/2016 Reg : 07:00  Use of Parsortix in GANNET53 drug trial
28/07/2016 Reg : 07:00  Preliminary Results
27/07/2016 Reg : 07:00  Initiation of 200 patient US ovarian cancer study
19/07/2016 Reg : 07:00  Initiation of European ovarian cancer study
15/07/2016 Reg : 07:00  Notice of Results
15/07/2016 Reg : 07:00  Parsortix gaining traction at EACR Conference
01/06/2016 Reg : 15:04  Holding(s) in Company
31/05/2016 Reg : 16:36  Holding(s) in Company
27/05/2016 Reg : 15:12  Edison issues research update on Angle
25/05/2016 Reg : 07:00  Placing
25/05/2016 Reg : 07:00  Cancer Research UK Contract
29/04/2016 Reg : 06:00  NEW PUBLICATIONS UTILISING PARSORTIX
19/04/2016 Reg : 12:43  Edison issues research update on Angle
18/04/2016 Reg : 07:00  Parsortix potential in metastatic breast cancer
21/03/2016 Reg : 12:12  Edison issues research update on Angle
21/03/2016 Reg : 07:00  Parsortix potential for prostate cancer detection
09/03/2016 Reg : 07:00  European patent grant for Parsortix
28/01/2016 Reg : 07:00  Interim Results
27/01/2016 Reg : 10:42  Notice of Interim Results
25/01/2016 Reg : 07:00  UKE publishes evaluation of Parsortix
22/12/2015 Reg : 07:00  Completion of Geomerics Transaction
15/12/2015 Reg : 07:00  Parsortix first commercial sales
10/12/2015 Reg : 07:00  Change of FTSE Industry Classification Benchmark
30/11/2015 Reg : 17:56  Holding(s) in Company
17/11/2015 Reg : 07:00  Lung Cancer Research Publication
12/11/2015 Reg : 14:17  ISSUE OF SHARE OPTIONS
14/10/2015 Reg : 07:00  Patent Grant
30/09/2015 Reg : 17:50  Result of AGM
28/09/2015 Reg : 07:00  Ovarian cancer results
24/09/2015 Reg : 07:00  Prostate cancer study published PLOS ONE Journal
09/09/2015 Reg : 07:00  BREAST CANCER RESULTS PRESENTED AT CDX CONFERENCE
08/09/2015 Reg : 15:54  Annual Report and Accounts and Notice of AGM
26/08/2015 Reg : 13:48  Issue of Equity and Total Voting Rights
23/07/2015 Reg : 07:00  Final Results
20/07/2015 Reg : 07:00  Notification of Preliminary Results
08/07/2015 Reg : 07:00  Appointment Of Scientific Adviser
11/06/2015 Reg : 07:00  Barts Prostate Cancer Update
03/06/2015 Reg : 07:00  Appointment of Scientific Adviser

back to top

Investis

15 minute delayed share price provided by vwd group

 
Site map |  Email alerts |  Contact us |